GLP-1s May Reduce Cancer Progression
Episode Description
GLP-1 drugs were designed for weight loss. Now they may be showing up in cancer research in a way nobody expected.
In this clip from our episode “The Business & Science Behind the GLP-1 Boom”, hosts David E. Williams and John Driscoll break down what the 2026 ASCO annual meeting revealed about GLP-1s and their potential to reduce cancer progression in lung, breast, colorectal, and liver cancer.
Listen to the full episode here
🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.
Listen On
